EatDrama
Lifestyle

STAT Plus: Breast cancer pill from AstraZeneca misses mark in pivotal trial

STAT Plus: Breast cancer pill from AstraZeneca misses mark in pivotal trial

The drug, approved for select patients as Etcamah, failed in a study in advanced tumors. It's being tested in early cancers as well.

Open original source

Article discussion

Comments stay attached to this story.

No comments yet.

Write a drama, celeb, gossip, or lifestyle post

Start a connected post from this article without changing the original story.

Featured Creators

Creators building their communities through the SpiderTaz Creator Program.

View creators →